JPH03187921A - Production of active substance - Google Patents

Production of active substance

Info

Publication number
JPH03187921A
JPH03187921A JP1270700A JP27070089A JPH03187921A JP H03187921 A JPH03187921 A JP H03187921A JP 1270700 A JP1270700 A JP 1270700A JP 27070089 A JP27070089 A JP 27070089A JP H03187921 A JPH03187921 A JP H03187921A
Authority
JP
Japan
Prior art keywords
active substance
solution
present
tissue
biological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1270700A
Other languages
Japanese (ja)
Other versions
JPH0761875B2 (en
Inventor
Shoji Yamashita
昭治 山下
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
I B II KK
Original Assignee
I B II KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58064298A external-priority patent/JPS59190226A/en
Application filed by I B II KK filed Critical I B II KK
Priority to JP1270700A priority Critical patent/JPH0761875B2/en
Publication of JPH03187921A publication Critical patent/JPH03187921A/en
Publication of JPH0761875B2 publication Critical patent/JPH0761875B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Cultivation Of Plants (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Iron (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Soil Conditioners And Soil-Stabilizing Materials (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 本発明は各種イオン反応の抑制作用、更には抗ウィルス
作用、抗癌作用、免疫作用等の生理作用を有する活性物
質の製造方法に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing an active substance that inhibits various ionic reactions and has physiological effects such as antiviral, anticancer, and immunological effects.

本発明者は硫酸第一鉄を多量の塩酸水溶液に投入して得
られる活性物質は水に溶解して該水を非イオン反応系に
変換し、各種のイオン反応を抑制して通常の水系におけ
るイオン反応による場合とは著しく異なる反応を誘導す
ることを見出した。
The present inventor has discovered that the active substance obtained by adding ferrous sulfate to a large amount of aqueous hydrochloric acid solution dissolves in water and converts the water into a nonionic reaction system, suppresses various ionic reactions, and can be used in ordinary aqueous systems. It has been found that this method induces a reaction that is significantly different from that caused by an ionic reaction.

そして正常な生体内反応はすべて上記活性物質によって
形成せられると同種な非イオン反応系で行われているこ
とは明らかである。そこで異常な生体に上記物質を導入
すれば生体内の非イオン反応系が回復し、生体は正常に
復帰することが出来る。
It is clear that all normal in-vivo reactions are carried out in the same type of nonionic reaction system formed by the above-mentioned active substances. Therefore, if the above-mentioned substance is introduced into an abnormal living body, the nonionic reaction system within the living body is restored, and the living body can return to normal.

かくして本発明により得られる上記活性物質はイオン反
応抑制作用にもとづく金属腐蝕抑制作用、塩障害除去作
用、土壌障害除去作用に加えて防腐作用、抗ウィルス作
用、抗癌作用、免疫作用等の生理作用を有するものであ
る。
Thus, the above-mentioned active substance obtained by the present invention has physiological effects such as antiseptic action, antiviral action, anticancer action, and immunological action in addition to metal corrosion inhibiting action, salt damage removal action, and soil damage removal action based on ionic reaction inhibition action. It has the following.

本発明により得られる活性物質は二価鉄と三価鉄との中
間の性質を示す鉄の塩酸塩であると思われ、二価鉄の塩
類を多量の塩酸水溶液に投入した場合に得られるもので
ある。以下に本発明の活性物質の製造方法の具体例を示
す。
The active substance obtained by the present invention is thought to be an iron hydrochloride having properties intermediate between divalent iron and trivalent iron, and is obtained when divalent iron salts are added to a large amount of aqueous hydrochloric acid solution. It is. Specific examples of the method for producing the active substance of the present invention are shown below.

1.0■の硫酸第一鉄(FeS04・7H7○)を10
0m1の0.5N塩酸水溶液中に投入し攪拌溶解した後
−夜装置する。生じた不溶性物質をシ戸別しf液を減圧
濃縮しデシケータ−中で乾燥する。得られた乾燥粉末に
10m1のイソプロピルアルコール80%水溶液を加え
て溶出成分を集め、減圧濃縮し溶媒を除去、乾燥させる
。上記抽出−濃縮−乾燥操作を数回繰返すことによって
0.6■の結晶が得られる。
1.0■ ferrous sulfate (FeS04・7H7○)
The mixture was poured into 0 ml of 0.5N aqueous hydrochloric acid solution, stirred and dissolved, and then set up overnight. The resulting insoluble substances are separated, and the liquid f is concentrated under reduced pressure and dried in a desiccator. Add 10 ml of an 80% aqueous solution of isopropyl alcohol to the obtained dry powder, collect the eluted components, concentrate under reduced pressure to remove the solvent, and dry. By repeating the above extraction-concentration-drying operation several times, 0.6 inch crystals are obtained.

本方法においては硫酸第一鉄以外、塩化第一鉄、硝酸第
一鉄、燐酸第一鉄、蟻酸第一鉄、酢酸第一鉄等の二価鉄
塩が用いられ得る。
In this method, other than ferrous sulfate, divalent iron salts such as ferrous chloride, ferrous nitrate, ferrous phosphate, ferrous formate, and ferrous acetate may be used.

該結晶の5重量%水溶液を作成し、その0.01m1を
ペーパークロマトグラフ用1紙No、51A(2αx4
0an)の下端から3an内側の個所にスポットし、n
−ブタノール:酢酸:水=5:1:4容量比混合物を展
開溶媒として20℃、15時間の上方展開を行う。展開
後該ア紙を乾燥させてから1重量%フェリシアン化カリ
ウム水溶液を発色試薬として濾紙に噴霧発色させると該
結晶の展開位置は1スポツトでRf=0.07であるこ
とが確認された。
A 5% by weight aqueous solution of the crystals was prepared, and 0.01 ml of it was placed on paper chromatograph paper No. 51A (2αx4
Spot 3an inside from the bottom edge of 0an),
-Upward development is carried out at 20° C. for 15 hours using a mixture of butanol:acetic acid:water=5:1:4 volume ratio as a developing solvent. After the development, the paper was dried and a 1% by weight potassium ferricyanide aqueous solution was sprayed onto the filter paper as a coloring reagent to develop color. It was confirmed that the crystal development position was 1 spot and Rf = 0.07.

3− 次いで同様のペーパークロマトグラフテストを塩化第一
鉄および塩化第二鉄の1=1当量当量物について行った
所、展開の結果は2スポツトとなりRf= 0 、09
5 (FeC1□)と、Rf=0.36(FeC1a)
であることが確認された。
3- Then, when a similar paper chromatography test was performed on 1=1 equivalent of ferrous chloride and ferric chloride, the result of development was 2 spots, Rf=0,09
5 (FeC1□) and Rf=0.36 (FeC1a)
It was confirmed that

上記ペーパークロマトグラフテストにより該結晶は塩化
第一鉄と塩化第二鉄の中間の性質を示し、混合物ではな
く単一化合物であることが推定される。
According to the paper chromatography test described above, the crystals exhibited properties intermediate between those of ferrous chloride and ferric chloride, and are presumed to be a single compound rather than a mixture.

次いで該結晶の0.1gを蒸溜水に溶かして100m1
とし可検液を作成する。その2.5mlを501容メス
フラスコにとり、0.1重量%オルソフェナントロリン
水溶液2.5ml、および酢酸ナトリウム−酢酸緩衝液
(pH4,5)2.5mlを加え、蒸溜水で標線まで充
たす。30分間室温に静置した後510nmで吸光度を
測定する。塩化第一鉄水溶液について同様の方法で得た
標準曲線から可検液の二価鉄を求めると0.019g/
 100mlであった。
Next, 0.1 g of the crystals was dissolved in distilled water to 100 ml.
Prepare a testable solution. Transfer 2.5 ml of the flask to a 501-volume volumetric flask, add 2.5 ml of 0.1% by weight aqueous orthophenanthroline solution and 2.5 ml of sodium acetate-acetic acid buffer (pH 4,5), and fill the flask up to the mark with distilled water. After standing at room temperature for 30 minutes, absorbance is measured at 510 nm. The divalent iron in the testable solution was determined from the standard curve obtained in the same manner for the ferrous chloride aqueous solution, and was 0.019 g/
It was 100ml.

次いで上記操作においてメスフラスコに再検液− を添加した際、予かしめ10重量%ヒドロキシルアミン
塩酸塩水溶液1.0mlを添加して三価鉄を二価鉄に還
元する。この場合に得られた二価鉄量は0.038g/
 100mlであった。したがって三価鉄量は0.03
8g/100m1−0.019g/100m1=0.0
19g/ 100mlとなり、該結晶中には二価鉄と三
価鉄とが当量台まれていることが示唆される。
Next, in the above operation, when the re-test solution is added to the volumetric flask, 1.0 ml of a pre-caulked 10% by weight hydroxylamine hydrochloride aqueous solution is added to reduce trivalent iron to divalent iron. The amount of divalent iron obtained in this case was 0.038g/
It was 100ml. Therefore, the amount of trivalent iron is 0.03
8g/100m1-0.019g/100m1=0.0
19 g/100 ml, suggesting that divalent iron and trivalent iron are present in equivalent amounts in the crystal.

本発明の活性物質は例えば塩化ナトリウム、硫酸ナトリ
ウム、塩化アンモニウム、硫酸アンモニウム、珪藻土、
ベントナイト、シリカ、アルミナ等の無機化合物、ビタ
ミン、ホルモン、蛋白質、脂質等の有機化合物に担持さ
れてもよく、その場合においても本発明の活性物質の作
用は変化することがない。
Active substances according to the invention include, for example, sodium chloride, sodium sulfate, ammonium chloride, ammonium sulfate, diatomaceous earth,
It may be supported on inorganic compounds such as bentonite, silica, and alumina, and organic compounds such as vitamins, hormones, proteins, and lipids, and even in such cases, the action of the active substance of the present invention remains unchanged.

以下に本発明の実施例を示す。Examples of the present invention are shown below.

実施例1(金属の防蝕) 本実施例は本発明にかかる活性物質の防蝕作用を示すも
のである。金属の腐蝕は金属表面で同種の金属間または
異種金属間に腐蝕電流が生ずることによって起る。従っ
て金属を本発明の活性物質を含む溶液で表面処理をする
ことによって防蝕をはかることができる。
Example 1 (Corrosion protection of metal) This example shows the corrosion protection effect of the active substance according to the present invention. Corrosion of metals occurs due to the generation of corrosion current between metals of the same type or between metals of different types on the metal surface. Therefore, corrosion protection can be achieved by surface treating metals with a solution containing the active substance of the present invention.

0.2印X 5 an X 5 anの鉄片を予かしめ
稀塩酸および蒸溜水で洗浄・乾燥させた後、本発明の活
性物質(2、5X 10−’g/ml) 、弗化水素酸
(1゜2 X 10−’g/ml)およびグルコース(
10−3g/ll1l)の混合溶液200m1中に入れ
、80℃で30分間処理した。
A 0.2 mark X 5 an 1°2 × 10-'g/ml) and glucose (
The mixture was placed in 200 ml of a mixed solution of 10-3 g/l 1 l) and treated at 80°C for 30 minutes.

処理した鉄片をHCI気流中で腐蝕試験を行ったところ
、無処理の鉄片は1時間後に既に顕著な腐蝕をみたが、
処理鉄片は6日間の腐蝕試験によっても腐蝕をみなかっ
た。
When the treated iron pieces were subjected to a corrosion test in an HCI air stream, the untreated iron pieces already showed significant corrosion after one hour, but
The treated iron pieces showed no corrosion even after a 6-day corrosion test.

実施例2(塩障害の除去) 本実施例は本発明の活性物質の塩障害除去作用を示すも
のである。電解質溶液とくに海水は含有する金属イオン
のために船舶や海上・沿岸産業に多大の障害をもたらし
ている。本発明の活性物質の適用によってこれらの障害
を除去することができる。
Example 2 (Removal of salt damage) This example shows the effect of the active substance of the present invention on removing salt damage. Electrolyte solutions, especially seawater, pose a great problem to ships and marine/coastal industries due to the metal ions they contain. These obstacles can be eliminated by application of the active substances according to the invention.

天然海水に10−12g/mlになるように本発明の活
性物質を加え、これに鉄粉、マンガン粉、銅粉を添加し
静置したところ、無処理海水では1日以内にすべて塩化
物を生じたが、処理海水では」−年以」−変化が起らな
かった。
When the active substance of the present invention was added to natural seawater at a concentration of 10-12 g/ml, iron powder, manganese powder, and copper powder were added and left to stand, all chlorides were removed from untreated seawater within one day. However, no changes occurred in the treated seawater since 2000.

実施例3(連作障害土壌の改質) 本実施例は本発明の活性物質の連作障害土壌の改質作用
を示すものである。同一作物を連作していくと作物によ
っては土壌中に病原菌の繁殖が烈しく起り殆んど収穫不
能に陥ることがある。その根本原因は土壌中に集積する
無機、有機物質のイオン反応によるものである。したが
って本発明の活性物質の導入によってこれらの障害を除
去することができる。
Example 3 (Improvement of continuous cropping impaired soil) This example shows the effect of the active substance of the present invention on improving continuous cropping impaired soil. When the same crop is continuously cultivated, depending on the crop, pathogenic bacteria may proliferate in the soil, making it almost impossible to harvest. The root cause is ionic reactions between inorganic and organic substances that accumulate in the soil. These obstacles can therefore be eliminated by the introduction of the active substances according to the invention.

大根栽培地(岐阜県下)で起ったフサリウムの繁殖を伴
った強度の連作障害土壌にNaC1を担体とした本発明
の活性物質を10−”g/mlになるように水で希釈し
、その希釈液を土が潤る程度に与え、常法通り大根を作
付した。その結果、処理土壌の作物はすべて健全に生育
し、対照区の収量100に対し、230の収量指数が得
られた。
The active substance of the present invention containing NaCl as a carrier was diluted with water to a concentration of 10-''g/ml in soil with severe continuous cropping damage accompanied by Fusarium proliferation that occurred in a radish cultivation area (Gifu Prefecture). The diluted solution was applied to the soil to moisten it, and radish was planted in the usual manner.As a result, all the crops in the treated soil grew healthy, and a yield index of 230 was obtained, compared to the yield of 100 in the control plot.

実施例4(生体組織保存) 本実施例は本発明の活性物質の生体組織保存作用を示す
ものである。
Example 4 (Biological Tissue Preservation) This example shows the biological tissue preservation effect of the active substance of the present invention.

生体組織は一度生体個体から離れると、生体システムが
破壊されて組織の機能が失われるために蛋白質、炭水化
物等の生体成分は直ちに分解をはじめる。本発明の活性
物質は生体システムを成立させる基本物質であるため、
生体組織を生体から切り出した後でも本発明の活性物質
を含む溶液中では組織の崩壊が起らない。
Once a biological tissue is separated from a living individual, biological components such as proteins and carbohydrates immediately begin to decompose because the biological system is destroyed and tissue functions are lost. Since the active substance of the present invention is a basic substance that establishes a biological system,
Even after the living tissue is excised from the living body, tissue disintegration does not occur in the solution containing the active substance of the present invention.

本発明の活性物質の10−’g/ml水溶液10m1に
a−tocopherolおよびUbiquj non
e (Co −enzymeQ7)各0.1gの混合物
を加えて懸濁させた後、エタノールで上記脂質部分を集
めた。かくして本発明の活性物質を担持する上記脂質が
得られる。
A-tocopherol and Ubiquij non
e (Co-enzymeQ7) 0.1 g of each mixture was added and suspended, and then the above lipid portion was collected with ethanol. The above lipid carrying the active substance of the invention is thus obtained.

この脂質に界面活性剤としてTween −200、1
gを加えて水に分散させ、順次蒸溜水で希釈し脂質濃度
で2 X 10−”M/ Lの調製液を作成した。
Tween-200, 1 is added to this lipid as a surfactant.
g was added and dispersed in water, and sequentially diluted with distilled water to prepare a preparation with a lipid concentration of 2 x 10-''M/L.

白ネズミを屠殺後、直ちに筋肉組織をビンに入れ、上記
処理液を加え、一部室気層を残して密栓し常温に静置し
た。同時に対照として筋肉組織に蒸溜水加えて密栓した
ものを並べて静置した。その結果、対照区は1週後から
組織が崩壊し、微生物が繁殖して水がはげしく涸渇した
。ところが処理区の検体は組織が崩れず、微生物の繁殖
が起らず、液は透明のまま1ケ月以上最初の状態を保っ
た。
Immediately after killing the white rat, the muscle tissue was placed in a bottle, the above-mentioned treatment solution was added, the bottle was tightly capped leaving a partial room air layer, and the bottle was allowed to stand at room temperature. At the same time, as a control, distilled water was added to the muscle tissue and the tissue was sealed tightly and allowed to stand side by side. As a result, the tissue in the control plot collapsed after one week, microorganisms multiplied, and water rapidly dried up. However, the tissue of the samples from the treatment area remained intact, no microbial growth occurred, and the liquid remained clear for more than a month.

実施例5(植物組織の再生) 本実施例は本発明の活性物質の植物組織の再生作用を示
すものである。
Example 5 (Regeneration of plant tissue) This example shows the regeneration effect of the active substance of the present invention on plant tissue.

本発明の活性物質を実施例4と同様にして脂質(α−t
ocopherol、 Ubiquinone)を担体
として合成し、脂質濃度で10−7M/Lの溶液で調製
し、その調製液にクロマツの切枝を30分浸漬した後、
石英砂を入れたポットに挿木した。対照区は全て枯死し
たが、処理したクロマツは活着した。
The active substance of the present invention was prepared in the same manner as in Example 4, and lipid (α-t
ocopherol, Ubiquinone) as a carrier, prepared in a solution with a lipid concentration of 10-7 M/L, and after immersing cut branches of Japanese black pine in the prepared solution for 30 minutes,
The cuttings were placed in pots filled with quartz sand. The control plots all died, but the treated black pines took root.

実施例6(生体成分の非生物合成) 本実施例は本発明の活性物質の生体成分の非生物合成す
る作用を示すものである。
Example 6 (Abiotic Synthesis of Biological Components) This example shows the effect of the active substance of the present invention on non-biological synthesis of biological components.

本発明の活性物質は生体内で、通常遺伝現象として知ら
れている体蛋白質の生合成に関与している。
The active substances of the invention are involved in the biosynthesis of body proteins in vivo, which is generally known as a genetic phenomenon.

本発明の活性物質を用いることによって非生物系で任意
の蛋白質を合成することができる。
By using the active substance of the present invention, any protein can be synthesized in an abiotic system.

1■のインシュリンを含む1%活性物質水溶液100m
1から本発明の活性物質を再抽出し、エタノールで洗浄
後乾燥精製した。この結晶を溶質とする新たな水溶液(
2,9x 10−’g/ Q)を調整し、ここに0.1
 gのシスチンを溶解し、その溶液を蒸溜水を外液とす
るセルロース膜の透析を行なった。透析チューブ内の生
成物10■を採取、結晶させ、種々の分析を行なったと
ころ、前と同一組成をもつインシュリンであることが確
認された。
100ml of 1% active substance aqueous solution containing 1■ insulin
The active substance of the present invention was re-extracted from No. 1, washed with ethanol, and then dried and purified. A new aqueous solution containing this crystal as a solute (
2,9x 10-'g/Q) and here 0.1
g of cystine was dissolved, and the solution was subjected to dialysis through a cellulose membrane using distilled water as the external liquid. Ten volumes of the product in the dialysis tube were collected, crystallized, and subjected to various analyses, and it was confirmed that the product was insulin having the same composition as before.

実施例7(防腐、防黴作用) 本実施例は本発明の活性物質の防腐、防黴作用を示すも
のである。本発明の活性物質は微生物に接触するとその
微生物の有する情報に従う新たな蛋白質合成機能を獲得
する。この現象は従来、抗原−抗体反応として理解され
てきたものである。
Example 7 (Preservative and antifungal effects) This example shows the antiseptic and antifungal effects of the active substance of the present invention. When the active substance of the present invention comes into contact with microorganisms, it acquires a new protein synthesis function according to the information possessed by the microorganisms. This phenomenon has conventionally been understood as an antigen-antibody reaction.

=9− 10− この抗体を利用して食品類の防腐、防黴をはかることが
できる。
=9-10- This antibody can be used to preserve foods and prevent mold.

本発明の活性物質を塩化マグネシウムを担体として合成
し、塩化マグネシウム濃度10−’g/mlの溶液を作
り処理液とした。
The active substance of the present invention was synthesized using magnesium chloride as a carrier, and a solution with a magnesium chloride concentration of 10-'g/ml was prepared and used as a treatment solution.

予かしめアサリおよび餅片を開放系で32℃に3日間静
置し、微生物を繁殖させた。生じた微生物を上記処理液
10m1を入れた試験管中に澱粉およびペプトン各0.
5gと共に入れ、32℃に5日間静置した。生じた懸濁
液0.1mlを100m1の水に添加し、この液を新鮮
なアサリおよび餅に潅水し、密封して常温に保存した。
The pre-caulked clams and mochi pieces were left standing at 32°C in an open system for 3 days to allow microorganisms to propagate. The resulting microorganisms were placed in a test tube containing 10ml of the above treatment solution, and 0.0% each of starch and peptone were added.
5g and left at 32°C for 5 days. 0.1 ml of the resulting suspension was added to 100 ml of water and this liquid was dipped into fresh clams and rice cakes, sealed and stored at room temperature.

対照区は何れも腐敗およびカビの発生をみたが、処理検
体では3週以上微生物の増殖が起らなかった。
The control plots all showed rot and mold growth, but no microbial growth occurred for more than 3 weeks in the treated samples.

実施例8(抗ウィルス作用) 本実施例は本発明の活性物質の抗ウィルス作用を示すも
のである。
Example 8 (Antiviral action) This example demonstrates the antiviral action of the active substance of the present invention.

本発明の活性物質によって維持されている生体システム
に対して外部からこれに変更を加える物質または要因が
侵入した場合、ここに生体機能の低下が起こりいわゆる
病変となって現われる。ウィルス感染障害は外部から核
酸が持込まれ生体システムが破壊されることによって生
ずるものである。従って本発明の活性物質を効果的に導
入することによって感染障害を除去することができる。
When a substance or factor that alters the biological system maintained by the active substance of the present invention invades from outside, the biological function deteriorates and appears as a so-called lesion. Viral infection disorders are caused by the introduction of nucleic acids from the outside and destruction of biological systems. Therefore, by effectively introducing the active substances of the present invention, infectious disorders can be eliminated.

予かしめトマトを宿主植物としてトマト葉にTMVを摂
取、生体増殖させた後、試験直前にトマト葉より汁液を
採取、水で500倍に希釈して試験用TMV懸濁液とし
た。
After ingesting TMV into tomato leaves using a pre-caulked tomato as a host plant and causing biological growth, the sap was collected from the tomato leaves immediately before the test and diluted 500 times with water to prepare a test TMV suspension.

約1ケ月後栽培したタバコ植物葉にカーボランダムを塗
布したのち、試験葉の半部に対照としてTMV懸濁液を
水で2倍希釈したもの、同−葉の他の半部にTMV懸濁
液を再検液で2倍希釈したものをそれぞれ綿に浸して塗
布した。再検液としては本発明の活性物質の2.9 X
 10 ’g/Q水溶液にMgC1,−6H2Oを1%
になるように添加したものを用いた。塗布後葉が乾いた
ところで(約30分後)残余のカーボランダムを水洗し
て、26℃のコイトトロン中で植物を培養した。
After about 1 month, carborundum was applied to leaves of cultivated tobacco plants, and half of the test leaves were treated with TMV suspension diluted 2 times with water as a control, and the other half of the test leaves were treated with TMV suspension. The solution was diluted 2 times with the retesting solution and applied to each cotton pad. The retest solution is 2.9X of the active substance of the present invention.
1% MgC1,-6H2O in 10'g/Q aqueous solution
I used the one that was added so that After the leaves dried after application (approximately 30 minutes later), the remaining carborundum was washed with water, and the plants were cultured in a coitotron at 26°C.

培養3日後に各試験葉に生じた斑点の数および再検物質
の阻止率を求めた結果は第1表に示す通りであった。
After 3 days of culture, the number of spots that appeared on each test leaf and the inhibition rate of the retested substance were determined, and the results are shown in Table 1.

第1表 活性物質溶液によるウィルス感染阻止 実施例9(制癌作用) 本実施例は本発明の活性物質の制癌作用を示すものであ
る。悪性腫瘍は、外界からのウィルスあるいは種々の発
癌性物質によって生体システムが極度に破壊され、正常
な細胞が異常細胞へ移行することによってひき起される
。ここに本発明の活性物質を導入することによって生体
システムが成立し異常細胞の増殖を阻止することができ
る。
Table 1 Inhibition of virus infection by active substance solution Example 9 (Anticancer effect) This example shows the anticancer effect of the active substance of the present invention. Malignant tumors are caused when biological systems are severely destroyed by viruses or various carcinogenic substances from the outside, and normal cells migrate to abnormal cells. By introducing the active substance of the present invention here, a biological system is established and the proliferation of abnormal cells can be inhibited.

本発明の活性物質の2.9X10−’g/Q水溶液に1
0m1にa −tocopherolおよびUbiqu
inone (C。
1 in a 2.9X10-'g/Q aqueous solution of the active substance of the invention.
a-tocopherol and Ubiqu in 0ml
inone (C.

−enzyme Q ? )各1.0gの混合物を加え
て懸濁させた後、エタノールで脂質部分を集めた。かく
して本発明の活性物質を担持する上記脂質が得られる。
-enzyme Q? ) After adding and suspending 1.0 g of each mixture, the lipid portion was collected with ethanol. The above lipid carrying the active substance of the invention is thus obtained.

この脂質にTveen −200、1gを加えた水に分
散させ、順次蒸溜水で希釈して調製液を作成し、各濃度
の調製液を基準として5ynthetic mediu
m 858の培養液を作成した。各脂質濃度の培養液で
ヒトの胃の健全部と癌組織をtrypsium消化して
得た細胞を24時間培養し、その細胞数を脂質を含まな
い培養液で培養した場合の細胞数を100とする指数で
あられすと第1図に示す通りであった。正常細胞の増殖
が起る2 X 10−”Mのところで異常細胞の明らか
な増殖抑制が認められた。
This lipid was dispersed in water with 1 g of Tveen-200 added, and diluted with distilled water in order to create a prepared solution. Based on the prepared solution of each concentration, 5 synthetic medium
A culture solution of m 858 was prepared. Cells obtained by trypsium digestion of healthy parts of the human stomach and cancerous tissue in culture media with various lipid concentrations are cultured for 24 hours, and the number of cells is 100 when cultured in a culture solution that does not contain lipids. Figure 1 shows the results of the index. Clear inhibition of abnormal cell growth was observed at 2 x 10-''M, where normal cell growth occurs.

実施例10(制癌作用) 本実施例は本発明にかかる活性物質の制癌作用を示すも
のである。生理食塩を担体とする本発明の活性物質複合
体を合成した。胃の幽門部に5aaX10anの腫瘍が
形成され、撤去手術は不可能な状態であった末期の胃癌
患者(♀、46オ)に対14− して手術を行なうことなく、上記活性物質複合体を1日
当り70■宛経ロ的に適用した結果、4週目より体力の
回復がみられ、3ケ月目より外出可能となり食事摂取量
が増し体重増がみられ、6ケ月後には通常の日常生活が
営める状況となった。
Example 10 (Anticancer effect) This example shows the anticancer effect of the active substance according to the present invention. An active substance complex of the present invention using physiological saline as a carrier was synthesized. The above active substance complex was administered to a terminal stage gastric cancer patient (♀, 46 years old) who had a 5aa x 10an tumor formed in the pyloric region of the stomach, and whose removal surgery was not possible. As a result of applying 70 ml per day, physical strength recovered from the 4th week, and from the 3rd month onward, they were able to go out, increased food intake, and gained weight, and after 6 months, they were able to resume normal daily life. We are now in a position where we can operate.

適用以来肝臓諸機能は正常な状態を保っている。Since application, liver functions have remained normal.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明の活性物質を含む培養液における増殖指
数を示すものである。 図中、□線は正常細胞 ・・・・線は異常細胞
FIG. 1 shows the proliferation index in culture medium containing the active substance of the invention. In the figure, the □ line is a normal cell...the line is an abnormal cell

Claims (1)

【特許請求の範囲】 二価鉄の塩類を多量の塩酸水溶液に投入し溶解させる工
程1 該溶液を放置し生じた不溶性物質を除去する工程2 不溶性物質を除去した該溶液を煮詰めて乾固物を得る工
程3 得られた乾固物をアルコール−水混合溶媒で抽出し、抽
出液を濃縮して結晶を得る工程4 以上の工程1、2、3、4からなる活性物質の製造方法
[Claims] Step 1: Adding salts of divalent iron to a large amount of aqueous hydrochloric acid solution to dissolve them. Step 2: Leaving the solution to remove the resulting insoluble substances. Boiling the solution from which the insoluble substances have been removed to form a solid product. Step 3: Extracting the obtained dry matter with an alcohol-water mixed solvent and concentrating the extract to obtain crystals Step 4: A method for producing an active substance consisting of the above steps 1, 2, 3, and 4.
JP1270700A 1983-04-11 1989-10-17 Method for producing active substance Expired - Lifetime JPH0761875B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1270700A JPH0761875B2 (en) 1983-04-11 1989-10-17 Method for producing active substance

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58064298A JPS59190226A (en) 1983-04-11 1983-04-11 Bivalent and trivalent iron salt and their preparation
JP1270700A JPH0761875B2 (en) 1983-04-11 1989-10-17 Method for producing active substance

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP58064298A Division JPS59190226A (en) 1983-04-11 1983-04-11 Bivalent and trivalent iron salt and their preparation

Publications (2)

Publication Number Publication Date
JPH03187921A true JPH03187921A (en) 1991-08-15
JPH0761875B2 JPH0761875B2 (en) 1995-07-05

Family

ID=26405419

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1270700A Expired - Lifetime JPH0761875B2 (en) 1983-04-11 1989-10-17 Method for producing active substance

Country Status (1)

Country Link
JP (1) JPH0761875B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020535223A (en) * 2017-09-26 2020-12-03 バイオコン バイオロジックス インディア リミテッドBiocon Biologics India Limited Integrated, automated filtration for peptide crystal separation, washing and drying

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020535223A (en) * 2017-09-26 2020-12-03 バイオコン バイオロジックス インディア リミテッドBiocon Biologics India Limited Integrated, automated filtration for peptide crystal separation, washing and drying

Also Published As

Publication number Publication date
JPH0761875B2 (en) 1995-07-05

Similar Documents

Publication Publication Date Title
Fell et al. Studies on the mode of action of excess of vitamin A. 4. The specificity of the effect on embryonic chick-limb cartilage in culture and on isolated rat-liver lysosomes
Millerd et al. Oxidative and phosphorylative activity of plant mitochondria
JPS59190226A (en) Bivalent and trivalent iron salt and their preparation
CN105586379A (en) Preparation method of collagen active peptide with cancer cell proliferation inhibition effect
Kannan et al. Growth, osmolyte concentration and antioxidant enzymes in the leaves of Sesuvium portulacastrum L. under salinity stress
JPH0363593B2 (en)
Morton et al. The preparation of crystalline forms of ferricytochrome b2 and ferrocytochrome b2
Sommer et al. Paralytic Shellfish Poison. I. Occurrence and Concentration by Ion Exchange1, 2, 3
JPH03187921A (en) Production of active substance
JP4709552B2 (en) LFA-1 inhibitor and use thereof
Agboola et al. Purified Azadirachta indica leaf arginase exhibits properties with potential tumor therapeutics: An Invitro Study
US4012502A (en) Snake venom inhibitor material and method of purification
JP2021505574A (en) Tumor cell abnormal lipid metabolism inhibitors containing plant-derived cyclic peptides as active ingredients and their use
JP2713725B2 (en) Ethylenediamine compound-iron complex
JP2003277271A (en) Anticancer agent
CN107698609A (en) Method and application based on human serum albumins IB subdomain synthesizing antitumor metal prodrugs
KR20210081711A (en) Manufacturing process of body fluid extract of sea squirt and the extract
Okada Antiviral effects of tea catechins and black tea theaflavins on plant viruses
JPH02298A (en) Cell growth regulator
Esaka et al. Stimulation of ascorbate oxidase secretion from cultured pumpkin cells by eosine yellowish and potassium salicylate
SU967484A1 (en) Method of producing alpha-fucosospecific lectine
CN101962399B (en) Method for extracting natural anti-tumor active protein and polypeptide from chickpea watercress
JPH05279368A (en) Production of chlorophyll a type compound and feed comprising the same product
JPS595274B2 (en) How to grow diatoms
JPS61158777A (en) Production of alga containing chromium